skip navigation

S M L Text size
Home » Results -- Early Manifest Glaucoma Trial (EMGT)

Results -- Early Manifest Glaucoma Trial (EMGT)

Co-sponsored by the National Eye Institute and Swedish Research Council

B-Roll available by calling 301-496-5248.

 

Bookmark or share this page

This page was last modified in October 2008
[ NEI Home | Contact Us | Site Map]
[ Web Site Policies and Important Links | Privacy Policy | FOIA | Information Quality Guidelines | FAQ ]
We welcome your questions and comments. Please send general questions and comments to the NEI Office of Communication, Health Education, and Public Liaison. Technical questions about this website can be addressed to the NEI Website Manager.

U. S. Department of Health and Human Services

National Institutes of Health

USA.gov


National Eye Institute
2020 Vision Place
Bethesda, MD 20892-3655
(301) 496-5248
www.nei.nih.gov
NEI Website Header Description: Confocal image of rat RPE layer two weeks after laser. A well-defined neovascular membrane labeled with Isolectin Ib4 (red) is detected below proliferating RPE cells (Phalloidin in green). New vessels are growing toward the subretinal space.